ADVFN Logo ADVFN

Wir konnten keine Ergebnisse für:
Stelle sicher, dass deine Schreibweise korrekt ist oder versuche deine Suche zu erweitern.

Trends

Toplisten

Es scheint, dass du nicht eingeloggt bist.
Klicke auf den Button unten, um dich einzuloggen und deine zuletzt angesehenen Aktien zu sehen.

Registrieren

Bereits Mitglied? Einloggen

Pepperstone

Jetzt Handeln

Pepperstone
Marktdaten
News
Werkzeuge
Märkte
Entdecken

Hot Features

Follow Feed

Vernetzen Sie sich mit Händlern und Investoren in unserer Follow-Feed-Community.

Optionen-Flow

Erkunden Sie umfassende Optionsdaten und nutzen Sie erweiterte Filter mit Options Flow.

Watchlist

Organisieren und überwachen Sie Ihre Aktien- und Vermögensbeobachtungsliste mit dem Monitor.
Anmelden Premium IconPremium Help Menu
DAX
19.322,59
0,91%
S&P 500
5.969,34
0,35%
Dow Jones
44.296,51
0,97%
Euro vs US Dollar
1,0418
0,00%
Bitcoin
98.906,50
-0,13%
Pepperstone
Advertisement
Registration Strip Icon for alerts Registrieren Sie sich für Echtzeit-Benachrichtigungen, benutzerdefinierte Portfolios und Marktbewegungen.
Registrieren
  1. Startseite
  2. Investieren
  3. Aktien
  4. USA
  5. USOTC

  6. Arno Therapeutics Inc (CE) (ARNI) Börsenkurse

Arno Therapeutics Inc (CE)

Arno Therapeutics Inc (CE) (ARNI)

USOTC
0,0001
0,00
(0,00%)
Geschlossen 23 November 10:00PM
Verzögert um 15 Minuten

Professionelle Tools für Privatanleger.

Premium

Wichtige Statistiken und Details

Current Price
0,0001
Gebot
0,00
Fragen
0,00
Volumen
-
0,00 Tagesbereich 0,00
0,000058 52-Wochen-Bereich 0,0003
Handelsende
0,0001
Handelsbeginn
-
Letzte Trade
Letzter Handelszeitpunkt
Durchschnittliches Volumen (3 Mio.)
9.989
Finanzvolumen
-
VWAP
-

ARNI Neueste Nachrichten

Weitere Nachrichten

Arno Therapeutics, Inc. Appoints Alexander Zukiwski, M.D. as Interim Chief Executive Officer and Mr. Lawrence Kenyon as Chief...

FLEMINGTON, N.J., July 18, 2014 (GLOBE NEWSWIRE) -- Arno Therapeutics, Inc. (OTCQB:ARNI), a clinical stage biopharmaceutical company focused on the development of oncology therapeutics, today...

18 Juli 2014
GlobeNewswire Inc.

Arno Therapeutics to Present at the Jefferies 2014 Global Healthcare Conference

FLEMINGTON, N.J., May 29, 2014 (GLOBE NEWSWIRE) -- Arno Therapeutics, Inc. (OTCQB:ARNI), a clinical stage biopharmaceutical company focused on the development of oncology therapeutics, today...

29 Mai 2014
GlobeNewswire Inc.

Arno Therapeutics Reports First Quarter 2014 Financial and Business Update

FLEMINGTON, N.J., May 15, 2014 (GLOBE NEWSWIRE) -- Arno Therapeutics, Inc. (OTCQB:ARNI), a clinical stage biopharmaceutical company focused on the development of oncology therapeutics, today...

15 Mai 2014
GlobeNewswire Inc.

Arno Therapeutics to Outline Two Phase I Studies Evaluating Onapristone in Men's and Women's Cancers at 2014 ASCO Annual Meet...

Studies to determine recommended Phase II dose and safety profile of lead compound Will analyze relationship of biomarker to any anti-tumor activity observed FLEMINGTON, N.J., May 14, 2014...

14 Mai 2014
GlobeNewswire Inc.

Arno Therapeutics Announces Clinical Abstracts Accepted at 2014 ASCO Annual Meeting

FLEMINGTON, N.J., May 5, 2014 (GLOBE NEWSWIRE) -- Arno Therapeutics, Inc. (OTCQB:ARNI), a clinical stage biopharmaceutical company focused on the development of oncology therapeutics, today...

05 Mai 2014
GlobeNewswire Inc.

Arno Therapeutics Enrolls First Patient in a Phase I/II Trial Evaluating Onapristone in Men with Advanced Castration-Resistan...

FLEMINGTON, N.J., April 7, 2014 (GLOBE NEWSWIRE) -- Arno Therapeutics, Inc. (OTCQB:ARNI), a clinical stage biopharmaceutical company focused on the development of oncology therapeutics, today...

07 April 2014
GlobeNewswire Inc.

Arno Therapeutics Reports 2013 Financial Results and Provides Update on Strategic and Operational Milestones

FLEMINGTON, N.J., April 1, 2014 (GLOBE NEWSWIRE) -- Arno Therapeutics, Inc. (OTCQB:ARNI), a clinical stage biopharmaceutical company focused on the development of oncology therapeutics, today...

01 April 2014
GlobeNewswire Inc.

Arno Therapeutics to Present Three New Studies Supporting the Clinical Development of Onapristone at AACR Annual Meeting 2014...

FLEMINGTON, N.J., March 26, 2014 (GLOBE NEWSWIRE) -- Arno Therapeutics, Inc. (OTCQB:ARNI), a clinical stage biopharmaceutical company focused on the development of oncology therapeutics, today...

26 März 2014
GlobeNewswire Inc.

Arno Therapeutics Board of Directors Appoints Randy Thurman as Vice Chairman

FLEMINGTON, N.J., March 24, 2014 (GLOBE NEWSWIRE) -- Arno Therapeutics, Inc. (OTCQB:ARNI), a clinical stage biopharmaceutical company focused on the development of oncology therapeutics, today...

24 März 2014
GlobeNewswire Inc.

Arno Therapeutics to Present at 26th Annual ROTH Conference

FLEMINGTON, N.J., March 5, 2014 (GLOBE NEWSWIRE) -- Arno Therapeutics, Inc. (OTCQB:ARNI), a clinical stage biopharmaceutical company focused on the development of oncology therapeutics, today...

05 März 2014
GlobeNewswire Inc.
Zeitraum †ÄnderungÄnderung %HandelsbeginnHochNiedrigDurchsch. VolumenVWAP
10000000CS
4000.00010.00010.0001149830.0001CS
12-0.0002-66.66666666670.00030.00030.000199890.0001CS
26-0.0002-66.66666666670.00030.00030.000149940.0001CS
524.2E-572.41379310345.8E-50.00035.8E-537570.00012027CS
156-0.002-95.23809523810.00210.00211.0E-662777.433E-5CS
260-0.0017-94.44444444440.00180.0421.0E-6621720.00489531CS

Beweger

Alle Anzeigen
  • Volumen
  • % Tops
  • % Flops
SymbolPreisVol.
NEPTFNeptune Wellness Solutions Inc (CE)
US$ 0,0238
(2.379.900,00%)
13,46k
CNVIFConavi Medical Corporation (PK)
US$ 0,58
(82.757,14%)
2,25k
FUNFFFansUnite Entertainment Inc (CE)
US$ 0,00055
(54.900,00%)
342,7k
RQHTFReliq Health Technologies Inc (CE)
US$ 0,0003
(29.900,00%)
219,11k
ELOXEloxx Pharmaceuticals Inc (CE)
US$ 0,0001
(9.900,00%)
1,53k
FDVXFFenixOro Gold Corporation (CE)
US$ 0,000001
(-100,00%)
10k
TMPOQTempo Automation Holdings Inc (CE)
US$ 0,000001
(-99,98%)
200
HLLPFHello Pal International Inc (CE)
US$ 0,000001
(-99,90%)
6k
MOTSMotus GI Holdings Inc (CE)
US$ 0,000001
(-99,88%)
649
BTAEFBeta Energy Corporation (CE)
US$ 0,000001
(-99,67%)
655
RSHNRushNet Inc (PK)
US$ 0,00015
(-25,00%)
502,31M
EARIEntertainment Arts Research Inc (PK)
US$ 0,0001
(0,00%)
428,38M
ASTAAstra Veda Corporation (PK)
US$ 0,0002
(-33,33%)
364,38M
RDARRaadr Inc (PK)
US$ 0,0009
(50,00%)
276,07M
CGACCode Green Apparel Corp (PK)
US$ 0,00065
(44,44%)
225,16M

Foren

Foren anzeigen
Keine Diskussionen Gefunden.
Neuen Thread Erstellen

Kürzlich von Ihnen besucht

USOTC
ARNI
Arno Therapeutics (CE)
Delayed Upgrade Clock
ADVFN Logo
InvestorsHub

Deutschland
Unternehmen
Geschäft
Popular
App herunterladen
App Store
Google Play

Support: +44 (0) 203 8794 460 | support@advfn.de

Durch das Benutzen des ADVFN Angebotes akzeptieren Sie folgende Allgemeine Geschäftsbedingungen

© 2024 ADVFN PLC - Alle Rechte vorbehalten